InMed’s INM-088 eye drop formulation utilizes a licensed ... submissions in anticipation of first human clinical trials with INM-088 in glaucoma in 2022. “As a leader in harnessing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback